Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab

Hematology Journal

Volumn 3, Issue 1, 2002, Pages 61-62

  Cohen, Yossi ^a   Polliack, Aaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DEXAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE; MONOCLONAL ANTIBODY;

ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CELLULITIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG RESPONSE; ERYTHEMA MULTIFORME; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; REMISSION; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; CHRONIC DISEASE; DISEASE FREE SURVIVAL; METHODOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION;

EID: 85047681045     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200148     Document Type: Letter

References (8)

1. Rituxan (rituximab) therapy for chronic cold agglutinin disease
2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
3. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia
4. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma
5. Refractory autoimmune thrombocytopenic purpura treatment with Rituximab
6. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
7. Overview of idiopathic thrombocytopenic purpura: New approach to refractory patients
8. A pilot study of anti-CD20 MoAb rituximab in patients with refractory immune thrombocytopenic purpura (ITP)